道瓊斯指數
50,198.17
漲跌
-561.25-1.11%
在 MEXC 探索美國生物科技板塊股票,涵蓋專注於藥物研發、基因治療及生物學研究的公司。比較股價、當日漲跌、市值和成交量,全面瞭解生物科技行業動態。

今日美股市場走勢分化,道瓊斯指數漲跌幅為 -1.11%,標普 500 指數為 -0.23%,納斯達克綜合指數為 +0.42%。個股方面,622 隻上漲、4,413 隻下跌,市場整體呈現分化格局。
| # | 股票 | 52 週價格區間 | |||||
|---|---|---|---|---|---|---|---|
| 1 | 安進AMGN | $443.00 | -0.81% | 13.98K | $239.62B | $312.38 - $483.99 | 0.02% |
| 2 | 吉利德科學GILD | $169.49 | +0.37% | 15.15K | $210.22B | $116.88 - $176.58 | 0.02% |
| 3 | ModernaMRNA | $196.92 | +0.61% | 124.92K | $79.68B | $22.28 - $280.80 | 0.00% |
| 4 | IQVIA HoldingsIQV | $258.04 | +0.45% | 194 | $42.52B | $154.50 - $284.50 | 0.00% |
| 5 | BiogenBIIB | $250.09 | -0.22% | 394 | $36.97B | $160.36 - $261.00 | 0.00% |
| 6 | Revolution MedRVMD | $161.08 | +0.27% | 12.19K | $34.84B | $69.50 - $224.31 | 0.00% |
| 7 | 英賽德INCY | $120.62 | +2.44% | 6 | $24.59B | $89.25 - $132.60 | 0.00% |
| 8 | Medpace HoldingsMEDP | $646.48 | -0.08% | 995 | $18.08B | $373.00 - $693.97 | 0.00% |
| 9 | ExelixisEXEL | $68.50 | +0.85% | 14.35K | $16.71B | $39.71 - $73.69 | 0.00% |
| 10 | Charles River Laboratories IntlCRL | $344.69 | +1.73% | 24 | $16.52B | $146.19 - $379.63 | 0.00% |
| 11 | NeurocrineNBIX | $163.11 | +0.79% | 942 | $16.51B | $122.14 - $186.12 | 0.00% |
| 12 | Bio-TechneTECH | $72.71 | -0.02% | 8.38K | $11.42B | $43.20 - $72.88 | 0.00% |
| 13 | Repligen CorpRGEN | $174.41 | +0.86% | 471 | $11.15B | $100.99 - $198.87 | 0.00% |
| 14 | Halozyme TherapHALO | $95.10 | -0.77% | 79 | $10.84B | $61.23 - $134.00 | 0.00% |
| 15 | KymeraKYMR | $122.23 | +0.46% | 1.83K | $10.44B | $63.69 - $142.92 | 0.00% |
| 16 | Krystal BiotechKRYS | $315.94 | -1.15% | 167 | $9.36B | $203.17 - $382.54 | 0.00% |
| 17 | VaxcytePCVX | $58.22 | +0.86% | 729 | $9.22B | $42.40 - $90.75 | 0.00% |
| 18 | CG OncologyCGON | $84.70 | +0.68% | 7.08K | $7.57B | $37.01 - $93.95 | 0.00% |
| 19 | Twist BioscienceTWST | $120.42 | +2.13% | 4.26K | $7.55B | $25.23 - $219.71 | 0.00% |
| 20 | ImmunitybioIBRX | $6.75 | -0.10% | 143.13K | $7.18B | $1.95 - $12.43 | 0.00% |
| 21 | ImmunovantIMVT | $33.59 | +0.96% | 9.81K | $6.95B | $21.86 - $45.42 | 0.00% |
| 22 | Kodiak SciencesKOD | $99.03 | +1.30% | 5.46K | $6.22B | $19.04 - $112.79 | 0.00% |
| 23 | Scholar RockSRRK | $48.20 | +0.50% | 2.99K | $5.88B | $37.54 - $61.76 | 0.00% |
| 24 | Adaptive BiotechnologiesADPT | $28.97 | -0.21% | 5.03K | $4.69B | $12.00 - $32.21 | 0.00% |
| 25 | Crispr TherapeuticsCRSP | $40.69 | -0.42% | 11.69K | $3.95B | $39.80 - $63.45 | 0.00% |
| 26 | TarsusTARS | $74.47 | +1.25% | 41 | $3.67B | $53.89 - $91.53 | 0.00% |
| 27 | 雷利療法RLAY | $16.28 | -1.89% | 8.29K | $3.60B | $6.28 - $21.27 | 0.00% |
| 28 | Iovance BiotherapeuticsIOVA | $7.54 | +0.75% | 45.45K | $3.49B | $2.08 - $15.37 | 0.00% |
| 29 | Denali TherapeuticsDNLI | $18.90 | +1.34% | 93 | $3.03B | $15.34 - $27.30 | 0.00% |
| 30 | ADMA Biologics IncADMA | $13.64 | -0.05% | 6.43K | $3.03B | $7.21 - $20.46 | 0.00% |
| 31 | Vericel Corp OrdVCEL | $59.17 | +0.90% | 105 | $3.02B | $28.95 - $59.75 | 0.00% |
| 32 | BeamBEAM | $21.32 | -0.86% | 5.92K | $2.21B | $20.23 - $38.26 | 0.00% |
| 33 | BioCryst PharmaBCRX | $7.36 | -0.30% | 10.84K | $1.89B | $6.23 - $11.22 | 0.00% |
| 34 | ReplimuneREPL | $19.80 | 0.00% | 614 | $1.88B | $1.50 - $23.54 | 0.00% |
| 35 | Maze TherapeuticsMAZE | $31.23 | -4.99% | 613.41K | $1.85B | $21.95 - $53.65 | 0.00% |
| 36 | Hemab TherapeuticsCOAG | $38.99 | -0.35% | 41 | $1.83B | $23.00 - $55.42 | 0.00% |
| 37 | Recursion PharmaceuticalsRXRX | $2.87 | -0.28% | 557.95K | $1.78B | $2.50 - $5.24 | 0.00% |
| 38 | Vir BiotechVIR | $9.28 | +1.64% | 1.20K | $1.59B | $5.32 - $14.38 | 0.00% |
| 39 | AbsciABSI | $8.46 | +1.06% | 14.78K | $1.46B | $2.24 - $12.54 | 0.00% |
| 40 | Taysha GeneTSHA | $4.10 | +2.63% | 1.67K | $1.34B | $3.46 - $7.30 | 0.00% |
| 41 | NovavaxNVAX | $7.98 | -0.87% | 29.83K | $1.32B | $6.20 - $13.38 | 0.00% |
| 42 | Vor BiopharmaVOR | $17.77 | -1.89% | 3.63K | $1.09B | $6.50 - $26.00 | 0.00% |
| 43 | Inhibrx BiosciencesINBX | $70.50 | +2.05% | 1.14K | $1.04B | $57.30 - $155.29 | 0.00% |
| 44 | Odyssey TherapeuticsODTX | $18.98 | 0.00% | 0 | $930.59M | $15.10 - $29.05 | 0.00% |
| 45 | MeiraGTxMGTX | $8.27 | -0.35% | 10 | $808.23M | $6.62 - $15.35 | 0.00% |
| 46 | Monte Rosa TherapeuticsGLUE | $8.90 | -1.87% | 208 | $760.51M | $8.83 - $25.77 | 0.00% |
| 47 | Aura BiosciencesAURA | $7.30 | -3.57% | 25 | $759.74M | $4.73 - $9.54 | 0.00% |
| 48 | OmniAbOABI | $5.08 | 0.00% | 792 | $740.24M | $1.35 - $5.45 | 0.00% |
| 49 | Prime MedicinePRME | $3.87 | -0.21% | 10.56K | $701.20M | $2.67 - $5.91 | 0.00% |
| 50 | Solid BiosciencesSLDB | $6.22 | -1.89% | 268 | $694.78M | $4.40 - $11.45 | 0.00% |
| 現貨美股(RealStocks) | 代幣化美股(Tokenized Stocks) | 股票合約(Stock Futures) | |
|---|---|---|---|
| 是什麼 | 美股上市公司的真實股份(現貨美股) | 與美股/ETF 掛鉤的區塊鏈代幣 | 以 USDT 保證金進行的股價合約交易 |
| 所有權 | 是 —— 真實持股 | 否 —— 僅為合成敞口 | 否 —— 僅為衍生品敞口 |
| 股東權益 | 有(如分紅) | 無 | 無 |
| 交易時間 | 美股交易時段(盤前、正常、盤後、隔夜) | 24/7 全天候 | 支援交易對最高可達 24/7 全天候 |
| 持倉方式 | 買入並持有 | 買入並持有 | 支援多空雙向、槓桿交易 |
| 適合人群 | 追求長期持有和分紅收益的投資者 | 希望全天候獲得股票敞口、無需持有股票的交易者 | 希望通過槓桿進行投機或對沖的短線/活躍交易者 |
通過 MEXC 合作的持牌券商購買真實美股,並可按適用條件享有股息等股東權益。
覆蓋 7,000+ 隻美國上市股票及 ETF,涵蓋科技、金融、醫療、消費等多個行業。
支持 USDT 轉入及 USDT/USD 轉換,更便捷地為 RealStocks 帳戶提供資金。
以具有競爭力的交易成本參與真實美股交易,讓更多資金用於投資策略。
本頁面展示的美股價格、指數、排行榜、圖表及其他市場數據可能來自第三方數據提供商,並可能存在延遲或誤差。MEXC 提供的相關信息僅供參考和教育用途,不對其準確性或完整性作出保證。頁面內容不構成任何金融或投資建議,也不構成買賣任何證券的推薦。美股交易存在風險,歷史表現不代表未來結果,用戶應在作出投資決定前進行獨立研究。